Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Terminated 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 2

Conditions

Neoplasms 2Lymphatic Metastasis 2Breast Neoplasms 2Rectal Neoplasms 1Prostatic Neoplasms 1Ovarian Neoplasms 1Neoplasm Metastasis 1Liver Neoplasms 1

Interventions

Trastuzumab 628Paclitaxel 577Cyclophosphamide 555Docetaxel 485Capecitabine 402Letrozole 376Fulvestrant 327Doxorubicin 294Carboplatin 279Tamoxifen 275Anastrozole 243exemestane 228Radiotherapy 218Epirubicin 211Bevacizumab 196palbociclib 189pertuzumab 186Vinorelbine 167Lapatinib 167Gemcitabine 166pembrolizumab 162Surveys and Questionnaires 139Exercise 136Magnetic Resonance Spectroscopy 123Fluorouracil 119Blood Specimen Collection 118eribulin 117Albumin-Bound Paclitaxel 117Drug Therapy 111130-nm albumin-bound paclitaxel 111

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Breast Neoplasms × gadofosveset trisodium × Clear all
NCT01609920 2016-11-10

Nodal Staging in Breast Cancer With MRL

Maastricht University Medical Center

Phase NA Terminated
97 enrolled
Breast

Breast Neoplasms, Lymphatic Metastasis

NCT01437865 2012-04-06

Gadofosveset for Axillary Staging in Breast Cancer Patients

Maastricht University Medical Center

Phase NA Completed
10 enrolled
Breast

Breast Neoplasms, Lymphatic Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡